Pharmaids Pharmaceuticals informs about outcome for board meeting

02 Mar 2024 Evaluate
Pharmaids Pharmaceuticals has informed that the Board of Directors of Pharmaids Pharmaceuticals (the Company) at its meeting held today, i.e., March 02, 2024, approved the allotment of 1,28,56,578 fully paid-up equity shares having face value of Rs 10 (Rupees Ten Only) each at a price of Rs 40.87 (including premium of Rs 30.87) per equity shares to the allottees given below as an Annexure A, for the consideration other than cash (i.e., being a full consideration for acquisition of 36,73,308 equity shares of Rs 10 (Rupees Ten Only) each of Adita Bio Sys (target company), on preferential basis by way of private placement. These shares shall rank pari-passu, in all respects with the existing equity shares of the company. The company has received in-principle approval from the Stock Exchange i.e., BSE for issue of the aforesaid Equity Shares on Preferential Basis on February 19, 2024. The Application for listing approval of the stock exchange for the equity shares allotted as above will be made in due course. The disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular on Continuous Disclosure (SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023), regarding the issue of equity shares on a preferential basis is enclosed as Annexure-I. The Board Meeting commenced at 11:30 am and concluded at 12:40 pm.

The above information is a part of company’s filings submitted to BSE.

Pharmaids Pharma Share Price

59.00 -1.49 (-2.46%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.